Full Text View
Tabular View
No Study Results Posted
Related Studies
Carbamazepine Extended-Release for the Treatment of Bipolar Depression
This study has been completed.
Study NCT00203567   Information provided by Tuscaloosa Research & Education Advancement Corporation
First Received: September 12, 2005   Last Updated: June 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Depression
Additional conditions recognized in this trial
Bipolar Disorder
Depression
Depressive Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
carbamazepine ER
Additional drug interventions recognized in this trial
Carbamazepine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anticonvulsants
Antimanic Agents
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Tuscaloosa Research &Education Advancement Corporation
Shire Pharmaceutical Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services